Arbutus Biopharma Corp.

( )
ABUS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. -0.94%240.321.3%$846.08m
MRNAModerna, Inc. -2.96%65.170.0%$695.63m
IMMUImmunomedics, Inc. 0.15%85.3011.0%$670.56m
NVAXNovavax, Inc. 0.86%102.4496.5%$610.34m
GILDGilead Sciences, Inc. -1.33%62.251.0%$565.51m
ILMNIllumina, Inc. 4.88%286.313.5%$473.05m
REGNRegeneron Pharmaceuticals, Inc. -1.37%557.462.7%$432.62m
BIIBBiogen, Inc. -0.79%270.041.6%$334.79m
VRTXVertex Pharmaceuticals, Inc. -0.26%263.131.9%$321.06m
ALXNAlexion Pharmaceuticals, Inc. -0.37%112.022.0%$277.96m
SRNESorrento Therapeutics, Inc. -4.27%9.191.5%$257.41m
MNTAMomenta Pharmaceuticals, Inc. 0.19%52.393.0%$205.44m
SGENSeattle Genetics, Inc. 0.09%179.436.0%$202.59m
VXRTVaxart, Inc. -4.17%6.890.0%$195.90m
BMRNBioMarin Pharmaceutical, Inc. -2.36%76.584.3%$192.95m

Company Profile

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.